Session » Abstracts: Vasculitis – ANCA-Associated I
- 1:00PM-2:30PM
-
Abstract Number: 0823
A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis with Polyangiitis
- 1:00PM-2:30PM
-
Abstract Number: 0825
Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator (BRAVO): 6-month Outcomes of a Longitudinal Cohort Study
- 1:00PM-2:30PM
-
Abstract Number: 0828
Efficacy of Eosinophil-Targeting Therapies on Specific Disease Manifestations of Eosinophilic Granulomatosis with Polyangiitis in the Phase 3 MANDARA Trial
- 1:00PM-2:30PM
-
Abstract Number: 0827
Oral Corticosteroid-Sparing Effects of Mepolizumab in Eosinophilic Granulomatosis with Polyangiitis (EGPA): Results up to 7.4 Years from the Long-Term Access Programme
- 1:00PM-2:30PM
-
Abstract Number: 0826
Plasma Exchange for Severe Alveolar Hemorrhage in ANCA-Associated Vasculitis: Emulation of a Target Trial